单位:[1]Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, Beijing, China临床科室肾脏内科肾脏内科首都医科大学附属北京友谊医院[2]Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, Beijing, China医技科室影像中心超声医学科首都医科大学附属北京友谊医院
Background: Microwave ablation (MWA) can be used to treat severe secondary hyperparathyroidism; however, its efficacy and the predictor of its efficacy are unclear. In this retrospective study we determined the predictor of efficacy of MWA and compared the efficacy of MWA and parathyroidectomy. Materials and methods: Patients with severe secondary hyperparathyroidism who had received MWA or parathyroidectomy were enrolled in the study. Participants with MWA were divided into response and no response groups based on efficacy. Possible predictors were analysed using logistic regression to determine efficacy predictors. The participants were divided into MWA and parathyroidectomy groups, and the efficacy (including rates of achieving recommended goals for intact parathyroid hormone (iPTH), calcium, and phosphorus levels) were compared between the two groups. Results: Thirty-one participants were enrolled for predictor analysis. Only baseline iPTH level predicted efficacy (OR 0.997, P = 0.018). The optimal threshold value of iPTH for predicting efficacy was 1493.5 pg/mL. To compare efficacy, 30 patients were enrolled in MWA (18/30) and parathyroidectomy (12/30) groups. The rates of achieving recommended goals for iPTH levels varied between 0 and 60%; a significant difference was found between the groups at 5 months (P = 0.01). However, in the parathyroidectomy group, the iPTH level and rate of iPTH <124 pg/mL (lower limit of target range) were significantly lower than in the MWA group after treatment (40-75% versus 0-16.7%). Conclusion: Baseline iPTH level is a good predictor of MWA efficacy for severe secondary hyperparathyroidism; parathyroidectomy is more effective for severe secondary hyperparathyroidism than MWA.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300607]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类|3 区医学
小类|3 区核医学4 区肿瘤学
最新[2025]版:
大类|3 区医学
小类|3 区肿瘤学3 区核医学
JCR分区:
出版当年[2014]版:
Q2RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGQ3ONCOLOGY
最新[2023]版:
Q2ONCOLOGYQ2RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者单位:[1]Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[1]Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, Beijing, China[*1]Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, 95 Yong’An Road, Beijing 100050, China
推荐引用方式(GB/T 7714):
Diao Zongli,Liu Xu,Qian Linxue,et al.Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis[J].INTERNATIONAL JOURNAL of HYPERTHERMIA.2016,32(6):614-622.doi:10.1080/02656736.2016.1194485.
APA:
Diao, Zongli,Liu, Xu,Qian, Linxue,Liu, Jing,Liu, Sha&Liu, Wenhu.(2016).Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis.INTERNATIONAL JOURNAL of HYPERTHERMIA,32,(6)
MLA:
Diao, Zongli,et al."Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis".INTERNATIONAL JOURNAL of HYPERTHERMIA 32..6(2016):614-622